FDA Investigator French
French has inspections in 1 countries as of 15 Aug 2023. French has collaborated with a combined 2025 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
333
Last Inspection Date:
15 Aug 2023
Investigator Role:
FDA Investigator (Contractor)
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alexandra A Carrico,
Amina Bashir,
Anthony R Petriella,
Azza Talaat,
Bernard P Heidt,
Bleta Vuniqi,
Brentley S Collins,
Brian J Mundo,
Brian M Campbell,
Brian P Putz,
Byron Ho, DVM,
Catherine V Quinlan,
Cathie S Marshall,
Charles I Ann,
Chelsea J Falkowski,
Chelsea J Snider,
Christi L Bellmore,
Christian D Lynch (CDL),
Christina Eggleston,
Crystal M Young Lewis,
Cynthia L Aycock,
Cynthia Li,
Danial S Hutchison,
Daniel J Brown,
Danny Tuntevski,
Darren S Morgan,
David J Gasparovich,
Dawn C Olenjack,
Deanna L Lampley,
Donald W Myrick,
Downer,
Dylan C Grippi,
Eliezar Ramos,
Elizabeth J Rigoni,
Emily J Orban,
Erin M Miller,
Erma Zaimova,
Gary Durbiel Goldner,
Gene D Arcy,
Geneve M Maxwell,
Geneve M Parks,
Geneve Maxwell,
Hartman,
Helen B Ricalde,
Hokenson,
Jacob A Clark,
Jacob G Lutz,
Jacqueline Mdiaz Albertini,
James K Ireland,
Janet L Bowen,
Jankowski,
Jeffrey A Sommers,
Jeffrey D Meng,
Joseph R Haynes,
Julia A Avery,
Kristina Mezin,
Kristina Nastovski,
Lauren E Burke,
Leslie A Paul,
Linda S Jozefiak,
Lisa M Thursam,
LTJG Aaron B Otis,
Margaret N Persich,
Marlon K Turner,
Martha Sullivan Myrick,
Martin R Vowell,
Matthew J Gretkierewicz,
Megan C Amye,
Michael A Moutray,
Michele L Forster, PhD,
Michele Perry Williams,
Michelle L Jones,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Myra K Casey,
Nicholas E Boyd,
Owens,
Patsy I Domingo,
Patsy J Domingo,
Paula A Trost,
Philip A Klimkewicz,
Prabhu P Raju,
Ralph A Erickson,
Raymond R Roy, PhD,
Rebecca E Dombrowski,
Richard T Riggie,
Robert C Coleman,
Robert G Taylor,
Robert M Barbosa,
Robert R Barbosa,
Rohn R Robertson,
Ronald G Crawford,
Ryan J Benedict,
Sanket N Patel,
Sarah E Rhoades,
Sarah M Napier,
Schwierjohann Schwierjohann, Lindsey,
Scott A Golladay,
Sonya M Lambkin,
State Agency,
Susan M Jackson,
Susan P Bruederle,
Theodore N Sietsema,
Thomas A Peter,
Thomas J Cosgrove,
Tonnie L Carter,
Tracey Asinjen Wiersma,
Tracey L Siebesma,
Twana R Chandler,
Vesa Vuniqi,
Victoria A Murray,
Wendy M Stark,
William D Tingley,
William G Craig,
William G Nelson
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more